Everything below concerns prohibited list. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-11-05. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 4963 Da for full-length thymosin beta-4 | Value applies to the parent protein; fragment products may differ |
| Appearance | White to off-white lyophilized powder | Typical form of supplied synthetic peptide |
| Solubility | Freely soluble in water | Polar peptide; dissolves readily in aqueous buffer |
| Storage of dry powder | −20 °C, desiccated, protected from light | Standard laboratory practice for peptides |
| Typical detection method | Liquid chromatography–tandem mass spectrometry | Used in purity testing and anti-doping analysis |
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
== Description == Small clump-forming from a robust, somewhat woody rootstock with erect, hispid, unbranched stems 25–40 cm (9.8–15.7 in) high. Basal leaves linear elliptic to narrowly lanceolate, 10–15 cm (3.9–5.9 in) long with stalks to 4 cm (1.6 in); stem leaves smaller and sessile, velvety-hairy. Flowers are yellow, 3.5–4.5 cm (1.4–1.8 in) long by 1.2–1.6 cm (0.5–0.6 in) across densely planted on the ends of stems and branches. It flowers from early to late summer. All aerial parts are pubescent.
== Disease eradication == Smallpox was certified as eradiated in 1980, showing to the world that a deadly disease can be wiped out by well-coordinated vaccination. This provided fuel for the growth of EPI and spawned strategies to eliminate other diseases:
Opportunism is also a key factor – the organized criminal or criminal group is likely to frequently reorder the criminal associations they maintain, the types of crimes they perpetrate, and how they function in the public arena (recruitment, reputation, etc.) in order to ensure efficiency, capitalization and protection of their interests.
Sources: en.wikipedia.org
FLAG-tag, or FLAG octapeptide, or FLAG epitope, is a peptide protein tag that can be added to a protein using recombinant DNA technology, having the sequence DYKDDDDK (where D=aspartic acid, Y=tyrosine, and K=lysine). It is one of the most specific tags and it is an artificial antigen to which specific, high affinity monoclonal antibodies have been developed and hence can be used for protein purification by affinity chromatography and also can be used for locating proteins within living cells. FLAG-tag has been used to separate recombinant, overexpressed protein from wild-type protein expressed by the host organism. FLAG-tag can also be used in the isolation of protein complexes with multiple subunits, because FLAG-tag's mild purification procedure tends not to disrupt such complexes. FLAG-tag-based purification has been used to obtain proteins of sufficient purity and quality to carry out 3D structure determination by x-ray crystallography. A FLAG-tag can be used in many different assays that require recognition by an antibody. If there is no antibody against a given protein, adding a FLAG-tag to a protein allows the protein to be studied with an antibody against the FLAG-tag sequence. Examples are cellular localization studies by immunofluorescence, immunoprecipitation or detection by SDS PAGE protein electrophoresis and Western blotting. The peptide sequence of the FLAG-tag from the N-terminus to the C-terminus is: DYKDDDDK (1012 Da).
is the timescale of the process under consideration. For room-temperature liquids, the right-hand side is about 10−14 seconds, which generally means that time-dependent processes involving translational motion can be described classically. At extremely low temperatures, even the macroscopic behavior of certain liquids deviates from classical mechanics. Notable examples are hydrogen and helium. Due to their low temperature and mass, such liquids have a thermal de Broglie wavelength comparable to the average distance between molecules.
According to The New York Times, Vice President Rodríguez's economic record of increasing her country's oil production and stabilizing its economy despite harsher US sanctions in recent years and her reputation among Venezuelan and foreign business leaders as a technocrat, had earned the respect of American officials. For her part, Rodríguez conveyed an offer to collaborate with US officials "within the framework of international law". Of Rodríguez, Trump said that "she's cooperating", threatened her if she did not, and maintained that he would demand "total access" by US oil interests. On 7 January, Marco Rubio stated that the US government has a three-stage plan for Venezuela: stability, recovery, then transition.
== Further reading == Slater, Anna G.; Cooper, Andrew I. (2015-05-29). "Function-led design of new porous materials". Science. 348 (6238) aaa8075. doi:10.1126/science.aaa8075. PMID 26023142. Satoh, Yusuke; Matsuno, Hirohiko; Yamamato, Takuya; Tajima, Kenji; Isono, Takuya; Satoh, Toshifumi (2017). "Synthesis of Well-Defined Three- and Four-Armed Cage-Shaped Polymers via "Topological Conversion" from Trefoil- and Quatrefoil-Shaped Polymers". Macromolecules. 50 (1): 97–106. Bibcode:2017MaMol..50...97S. doi:10.1021/acs.macromol.6b02316. Mato, Yoshinobu; Honda, Kohei; Tajima, Kenji; Yamamato, Takuya; Isono, Takuya; Satoh, Toshifumi (2019). "A versatile synthetic strategy for macromolecular cages: intramolecular consecutive cyclization of star-shaped polymers". Chemical Science. 10 (2): 440–446. doi:10.1039/C8SC04006K. PMC 6335864. PMID 30746091. Lee, Taeheon; Oh, Joongsuk; Jeong, Jonghwa; Jung, Haeji; Huh, June; Chang, Taihyun; Paik, Hyun-jong (2016-05-24). "Figure-Eight-Shaped and Cage-Shaped Cyclic Polystyrenes". Macromolecules. 49 (10): 3672–3680. Bibcode:2016MaMol..49.3672L. doi:10.1021/acs.macromol.6b00093. ISSN 0024-9297.
Sources: en.wikipedia.org
These oligosaccharides are used in combination to improve the beneficial gut bacteria while eliminating the harmful gut bacteria. The aging dog goes through changes in brain and cognitive health. There are two highly important ingredients that can be included in senior dog foods to help prevent cognitive decline and improve brain health. These ingredients are vitamin E and L-carnitine. Vitamin E acts as an antioxidant, which can prevent oxidative damage that occurs during aging. L-carnitine is used to improve mitochondrial function, which can also help to prevent and lower rates of oxidative damage. Skin and coat health is important in all dogs, but especially becomes important as dogs age. An important nutrient to look for in senior dog foods to support coat health is linoleic acid, which can be found in corn and soybean oil. Another important nutrient is vitamin A, which helps with keratinization of hair. Good sources of vitamin A for skin and coat health include egg yolk and liver. Immune system health has been shown to decline in aging dogs. The ratio of omega-6 to omega-3 fatty acids plays an important role in providing optimal health. Vitamin E can be used as an antioxidant in senior dog foods. Pre- and probiotics can also be added to senior dog foods to help improve the beneficial bacteria in the gut, providing support for the immune system.
In November, Carrington destroyed villages adjacent to his line of communication and advanced towards Morija. In early December, he set up camp at Tsita's Nek, engaging in multiple clashes with the Basuto on the road to Morija. On 14 January 1881, Colonel Brabant led a force of 380 cavalry, 180 infantry, 400 armed burghers, and two 7-pounder guns towards Thaba Tsueu. Brabant sent the burghers ahead to capture the Radiamari village. After burning Radiamari, the burghers disregarded their orders and pushed further into Sepechele village, which was held by 8,000 men under Lerotholi. Chief Maama charged the burghers with 3,000 of his warriors, and the latter began to withdraw towards the rest of the Cape force. The Basuto managed to close in on the burghers but were eventually beaten off with carbine and artillery fire. As Maama retired, Lerotholi's warriors opened heavy fire from the surrounding ridges. Surgeon John Frederick McCrea of the 1st CMY won the Victoria Cross for attending injured burghers while being wounded himself. Brabant sent 140 riders from the Yeomanry in pursuit of Maama. The initial counter-attack failed after it was outflanked from the right. The Cape troops then dismounted and cleared the plateau and surrounding ridges. The Basuto suffered heavy casualties, while the Cape lost 16 killed and 21 wounded. Brabant then returned to his camp at Tsita's Nek. For most of the war the Cape's troops and administration remained isolated in the Hlotse, Maseru, and Mafeteng Districts. The lack of offensive action reduced the Cape troops' morale still further.
smooth endoplasmic reticulum (SER) A type of membrane in the endoplasmic reticulum that lacks ribosomes on its surface, thus visibly contrasting with the "rough" endoplasmic reticulum. Smooth ER tends to be tubular rather than sheet-like, and may form an extension of the rough ER or exist separately. It is especially abundant in cells concerned with lipid metabolism.
Sources: en.wikipedia.org
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.
No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.
It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.